loader2
Partner With Us NRI

Aug 05, 2022


Category

Others

AUM (Cr.)

82.50

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.21

Sharpe Ratio

-6.47

Beta Ratio

0.00

Fund Manager

Mehul Dama

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

Period(Year)

Amount

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF 5.92 -4.36 -10.79 0 0 -8.9
Benchmark - Nifty Pharma TRI 5.94 -4.28 -10.6 19.19 7.67 0
Category Average - BEST ETFS/INDEX 7.91 82.54 6.06 15.45 10.92 20.48
Category Rank 2/1 1/1 1/1 1/1 1/1 1/1
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Mirae Asset Hang Seng TECH ETF 14.8620 0.67 0.00 0.00 0.00 129.35 0.00 5,000.00 invest
Motilal Oswal NASDAQ-100 ETF 103.1909 0.65 -5.55 25.49 22.75 4,911.31 0.57 10,000.00 invest
AXIS Nifty IT ETF 307.8677 0.64 -2.11 0.00 0.00 24.76 0.22 5,000.00 invest
ICICI Pru Nifty IT ETF 309.6863 0.64 -2.13 0.00 0.00 1,744.86 0.20 5,000.00 invest
Nippon India ETF Nifty 1D Rate Liquid BeES 1,000.0000 -57.76 3.32 1.67 1.01 5,549.08 0.67 2,500,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Jul 31, 2022 21.15 24.00 15.32
Equity-Cipla Jul 31, 2022 10.98 12.45 8.22
Equity-Dr Reddy`s Labs Jul 31, 2022 10.32 11.71 -5.44
Equity-Divi`s Lab. Jul 31, 2022 10.14 11.51 7.19
Equity-Laurus Labs Jul 31, 2022 4.26 4.83 14.23
Equity-Alkem Lab Jul 31, 2022 3.28 3.73 9.21
Equity-Lupin Jul 31, 2022 3.22 3.66 7.07
Equity-Aurobindo Pharma Jul 31, 2022 3.20 3.63 8.27
Equity-Torrent Pharma. Jul 31, 2022 3.12 3.54 8.61
Equity-Biocon Jul 31, 2022 2.91 3.30 1.17

latest news

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 August 2022 as the record date fo...

Aug 08, 2022 07:23

Nippon India Mutual Fund Announces Appointment of Key Personnel

Nippon India Mutual Fund has announced that Advait Lath has been appointed ...

Aug 03, 2022 12:44

Nippon India Mutual Fund Announces change in Minimum Application Amount & Minimum Additional Investment under two schemes

Nippon India Mutual Fund has decided to revise Minimum Application Amount &...

Aug 01, 2022 11:36

Nippon India Balanced Advantage Fund Announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 July 2022 as the record date for ...

Jul 07, 2022 10:00

Nippon India Mutual Fund Announces change in scheme name under its schemes

Nippon India Mutual Fund has announced change in scheme name of the followi...

Jun 24, 2022 11:39

Nippon India MF Announces Quarterly Income Distribution cum Capital Withdrawal (IDCW) under its schemes

Nippon India Mutual Fund has announced 20 June 2022 as the record date for ...

Jun 15, 2022 10:29

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Mehul Dama
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com